Edition:
United Kingdom

Biolife Solutions Inc (BLFS.OQ)

BLFS.OQ on NASDAQ Stock Exchange Capital Market

20.27USD
13 Sep 2019
Change (% chg)

-- (--)
Prev Close
$20.27
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
54,638
52-wk High
$22.38
52-wk Low
$9.19

Latest Key Developments (Source: Significant Developments)

BioLife Solutions To Acquire SAVSU Technologies
Monday, 8 Jul 2019 

July 8 (Reuters) - Biolife Solutions Inc ::BIOLIFE SOLUTIONS TO ACQUIRE SAVSU TECHNOLOGIES.BIOLIFE SOLUTIONS INC - ACQUISITION WILL BE PURSUANT TO A SHARE PURCHASE AGREEMENT AND IS EXPECTED TO CLOSE WITHIN 45 DAYS..BIOLIFE SOLUTIONS INC - EXERCISED ITS OPTION TO ACQUIRE REMAINING 56% OF OUTSTANDING SHARES OF PRIVATELY HELD SAVSU TECHNOLOGIES.BIOLIFE SOLUTIONS INC - DEAL INCLUDES ALL SAVSU INTELLECTUAL PROPERTY COMPRISED OF 15 PENDING, ISSUED U.S. PATENTS RELATED TO COLD CHAIN TECHNOLOGIES.BIOLIFE SOLUTIONS INC - TWENTY-THREE SAVSU EMPLOYEES ARE JOINING BIOLIFE TEAM.BIOLIFE SOLUTIONS INC - SAVSU ALSO HAS A CONTRACT SALES ORGANIZATION COVERING EUROPE.  Full Article

BioLife Solutions Q4 Earnings Per Share $0.04
Thursday, 14 Mar 2019 

March 14 (Reuters) - Biolife Solutions Inc ::BIOLIFE SOLUTIONS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS.Q4 EARNINGS PER SHARE $0.04.Q4 REVENUE $5.5 MILLION.SEES FY 2019 REVENUE $27 MILLION TO $30 MILLION.  Full Article

Biolife Solutions Expands Cell And Gene Therapy Tools Portfolio With Acquisition Of Astero Bio
Thursday, 14 Mar 2019 

Biolife Solutions Inc ::BIOLIFE SOLUTIONS EXPANDS CELL AND GENE THERAPY TOOLS PORTFOLIO WITH ACQUISITION OF ASTERO BIO.BIOLIFE SOLUTIONS INC - PROVIDES ACCESS TO ADDRESSABLE MARKET PROJECTED TO EXCEED $150 MILLION BY 2024.BIOLIFE SOLUTIONS INC - PROPOSED DEAL FOR UPFRONT CASH PAYMENT OF $8.0 MILLION.BIOLIFE SOLUTIONS INC - GAINS PRODUCTS THAT AUTOMATE THAWING PROCESS FOR HIGH-VALUE BIOLOGIC THERAPIES.BIOLIFE SOLUTIONS INC - ENTERED INTO AN AGREEMENT TO ACQUIRE ASTERO BIO CORPORATIO FOR AN UPFRONT CASH PAYMENT OF $8.0 MILLION.  Full Article

Biolife Solutions Reports Q3 Earnings Per Share Of $0.05
Thursday, 8 Nov 2018 

Nov 8 (Reuters) - Biolife Solutions Inc ::BIOLIFE SOLUTIONS ANNOUNCES THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 EARNINGS PER SHARE $0.05.Q3 REVENUE ROSE 79 PERCENT TO $5.3 MILLION.BIOLIFE SOLUTIONS - AFFIRMING BIOPRESERVATION MEDIA REVENUE GUIDANCE FOR FY 2018 OF $19 MILLION TO $20 MILLION, REPRESENTING GROWTH OF 72% TO 82% OVER 2017.  Full Article

Biolife Solutions Reports Q3 Revenue Rose 79 Pct To $5.3 Mln
Monday, 1 Oct 2018 

Oct 1 (Reuters) - Biolife Solutions Inc ::BIOLIFE SOLUTIONS REPORTS RECORD THIRD QUARTER 2018 PRELIMINARY REVENUE OF $5.3 MILLION, UP 79% YEAR-OVER-YEAR.Q3 REVENUE ROSE 79 PERCENT TO $5.3 MILLION.SEES 2018 BIOPRESERVATION MEDIA REVENUE TO BE IN A RANGE OF $19 MILLION TO $20 MILLION.ENDED QUARTER WITH $32.4 MILLION IN CASH.  Full Article

Biolife Solutions Q2 Revenue Rose 103 Pct To $5.2 Mln
Monday, 2 Jul 2018 

July 2 (Reuters) - BioLife Solutions Inc ::BIOLIFE SOLUTIONS REPORTS SECOND QUARTER 2018 PRELIMINARY REVENUE OF $5.2 MILLION, UP 103% YEAR-OVER-YEAR AND 36% SEQUENTIALLY.Q2 REVENUE ROSE 103 PERCENT TO $5.2 MILLION.SAYS BIOPRESERVATION MEDIA REVENUE IS NOW EXPECTED TO BE IN A RANGE OF $18.5 MILLION TO $20 MILLION FOR FY 2018.SAYS FY 2018 GROSS MARGIN IS EXPECTED TO BE BETWEEN 63% AND 65%, UP FROM 61% FOR 2017.  Full Article

BioLife Solutions Reports Q1 Loss Per Share $0.01
Thursday, 10 May 2018 

May 10 (Reuters) - BioLife Solutions Inc ::BIOLIFE SOLUTIONS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.01.Q1 REVENUE ROSE 61 PERCENT TO $3.8 MILLION.AFFIRMING BIOPRESERVATION MEDIA REVENUE IS NOW EXPECTED TO RANGE BETWEEN $14.5 MILLION TO $15.5 MILLION FOR 2018.AFFIRMING FULL-YEAR GAAP OPERATING PROFIT, WITH PROPORTIONAL INCREASES IN ADJUSTED EBITDA AND CASH FLOW FROM OPERATIONS.INCREASING 2018 GROSS MARGIN GUIDANCE TO 63% TO 65%.  Full Article

BioLife Solutions Q4 Loss Per Share $0.05
Thursday, 8 Mar 2018 

March 8 (Reuters) - BioLife Solutions Inc ::BIOLIFE SOLUTIONS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS.Q4 LOSS PER SHARE $0.05.REAFFIRMS GUIDANCE FOR 2018 OPERATING PROFIT.QTRLY REVENUE $3.1 MILLION VERSUS $2.3 MILLION.  Full Article

Biolife Solutions Announces Preliminary 2017 Revenue Increase Of 34% To $11 Million
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - Biolife Solutions Inc ::BIOLIFE SOLUTIONS ANNOUNCES PRELIMINARY 2017 REVENUE INCREASE OF 34% TO $11 MILLION.Q4 REVENUE ROSE 39 PERCENT TO $3.1 MILLION.- FOR FULL YEAR 2017, PRELIMINARY REVENUE WAS $11 MILLION, A 34% INCREASE FROM 2016.- IN 2018, GROSS MARGIN IS EXPECTED TO RANGE BETWEEN 62% TO 64%.BIOLIFE SOLUTIONS - ‍FOR FY18 BIOPRESERVATION MEDIA REVENUE IS EXPECTED TO RANGE $13.6 MILLION -$14.7 MILLION, REPRESENTING GROWTH OF 25% TO 35% OVER 2017​.  Full Article

Biolife Solutions Executes Supply Agreement With Iovance Biotherapeutics
Wednesday, 13 Dec 2017 

Dec 13 (Reuters) - Biolife Solutions Inc ::BIOLIFE SOLUTIONS EXECUTES SUPPLY AGREEMENT WITH IOVANCE BIOTHERAPEUTICS.BIOLIFE SOLUTIONS - EXECUTED AGREEMENT TO SUPPLY CRYOSTOR CELL FREEZE MEDIA AND HYPOTHERMOSOL STORAGE AND SHIPPING MEDIA TO IOVANCE BIOTHERAPEUTICS.  Full Article